LIXTE BIOTECHNOLOGY HOLDINGS, INC. (NMAD) Total liabilities 2010–2015
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (NMAD) total liabilities at each fiscal year-end, per SEC filings.
$285,642FY2015 · since FY2010: $195,062 → $285,642
| Fiscal year | Value | YoY |
|---|---|---|
| FY2015 | $285,642 | — |
| FY2013 | $321,774 | +23.2% |
| FY2012 | $261,152 | -25.5% |
| FY2011 | $350,746 | +79.8% |
| FY2010 | $195,062 | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice